Calocurb is a plant-based nutraceutical from New Zealand that has gained attention for its patented and clinically proven formula. The product claims to reduce hunger by 30%, cravings by 40%, and calorie intake by 18%, using a unique extract from the hops flower. What sets Calocurb apart is its $30m investment in research and development, spanning over 14 years. The active ingredient has been developed and clinically tested by leading scientists from Plant & Food Research, showcasing the brand's commitment to scientific rigor. Furthermore, Calocurb is marketed as all natural, vegan, and certified non-GMO, offering a caffeine-free solution for individuals looking to manage their appetite. With its ability to take effect within one hour, Calocurb aims to provide a fast-acting solution for curbing hunger, making it a potentially appealing prospect for investors in the nutraceutical and wellness space.
There is no investment information
No recent news or press coverage available for Calocurb.